An Open Letter to the Food and Drug Administration and Pharmaceutical Industry Concerning Drug Approval for Children With Inflammatory Bowel Disease.
作者信息
Hyams Jeffrey S, Winter Harland S, Mulberg Andrew E, Zuckerman Eric
机构信息
Connecticut Children's Hartford, CT, USA.
MassGeneral Hospital for Children Boston, MA, USA.
出版信息
Inflamm Bowel Dis. 2024 Dec 5;30(12):2523-2525. doi: 10.1093/ibd/izae226.
PMID:39377256
Abstract
摘要
Zotero 插件